financetom
Business
financetom
/
Business
/
Enliven Therapeutics Insider Sold Shares Worth $685,868, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enliven Therapeutics Insider Sold Shares Worth $685,868, According to a Recent SEC Filing
Jan 10, 2025 2:50 PM

05:37 PM EST, 01/10/2025 (MT Newswires) -- Anish Patel, COO, on January 07, 2025, sold 28,367 shares in Enliven Therapeutics ( ELVN ) for $685,868. Following the Form 4 filing with the SEC, Patel has control over a total of 336,644 shares of the company, with 336,644 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1672619/000141588925001301/xslF345X05/form4-01102025_100148.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved